“…by guest www.bloodjournal.org From Because marrow stromal cells are a heterogenous cell population and comprise fibroblast-like cells, macrophages, and endothelial cells, we next determined if the differences between MM patient-derived and normal stromal cells were due to a change in the distribution of cell types present in the stromal cell preparations, such as enrichment or loss of a particular cell type that affected the capacity of the stromal cell preparations to stimulate the growth of MM cells. Both MM and normal stromal cells contained similar percentages of cells that expressed CD63 (88.5 Ϯ 1.4 vs 88.4 Ϯ 1.8, mean Ϯ standard deviation [SD] for healthy vs MM patients, n ϭ 5) and CD51 (86 Ϯ 0.5 vs 90 Ϯ 3, mean Ϯ SD for healthy vs MM patients, n ϭ 5) 23,24 and that had low expression of CD14 (11 Ϯ 1 vs 12 Ϯ 0.3, mean Ϯ SD for healthy vs MM patients, n ϭ 5; Figure 1D). The hematopoietic cell marker for the monocyte lineage (CD11b) was not detected in either stromal cell preparation (data not shown).…”